期刊文献+

RNAi沉默Sp3基因对裸鼠人肝癌种植瘤细胞侵袭能力的影响 被引量:2

RNAi-mediated silencing of Sp3 expression reduces invasion of HepG2 cells in a xenogeneic graft mouse model
在线阅读 下载PDF
导出
摘要 目的:构建裸鼠人肝癌种植瘤模型,观察沉默特异性蛋白3(specificity protein 3,Sp3)对裸鼠人肝癌种植瘤侵袭能力的影响,并探讨其机制.方法:将Sp3 shRNA转染人肝癌HepG2细胞,并设无关序列阴性组及空白组为对照,建立3组裸鼠人肝癌种植瘤模型.观察裸鼠肿瘤的成瘤率,瘤体进行HE染色观察其病理学改变,采用Real-time PCR及免疫组织化学检测瘤组织中Sp3、β-连接素(β-catenin)、E-钙黏附蛋白(E-cadherin)及基质金属蛋白酶9(matrix metalloproteinase 9,MMP-9)mRNA和蛋白的表达情况.结果:实验组的成瘤率明显低于其他两组(60%vs 100%,100%);HE观察实验组肿瘤细胞侵袭能力明显降低.荧光定量PCR检测结果显示,种植瘤中实验组的Sp3、β-catenin及MMP-9 mRNA相对表达量明显低于空白组及阴性组,差异有统计学意义(F=29.692,P=0.001;F=21.894,P=0.002;F=109.414,P<0.001);实验组瘤体中E-cadherin mRNA的相对表达量高于其他两组(F=66.983,P<0.001).免疫组织化学结果显示,实验组Sp3蛋白表达为30±5.69、β-catenin蛋白表达为28±5.13、MMP-9蛋白表达为97±10.41均低于空白组及阴性组;E-cadherin蛋白表达为132±4.36明显高于其他两组,差异有统计学意义(P=0.000).结论:Sp3可通过上调β-catenin及其下游基因MMP-9表达,同时下调E-cadherin的表达,增强人肝癌细胞的侵袭能力. AIM: To observe the influence of specificity protein 3 (Sp3) silencing on invasion of HepG2 cells in a xenogeneic graft mouse model, and to explore the possible mechanisms involved. METHODS: A shRNA-Sp3 or non-relevantshRNA was transfected into HepG2 cells using a lentiviral vector. Non-transfected HepG2 cells were used as controls. The three groups of cells were injected into nude mice. Tumor formation rate was determined, and the pathological mor- phology of cells in three groups was observed. The mRNA and protein expression of Sp3, β-catenin, E-cadherin and matrix metallopepti- dase 9 (MMP-9) was detected by real-time PCR and immunohistochemistry. RESULTS: The tumor formation rate was low- er in the shRNA-Sp3 group than in the non-rel- evant group and control group (60% vs 100%, 100%). The ability of invasion was weaker in the shRNA-Sp3 group. The expression of Sp3, β-catenin and MMP-9 mRNAs in the shRNA- Sp3 group was significantly lower than that in the non-relevant group and control group (F = 29.692, 21.894, 109.414; P = 0.001, 0.002, 〈 0.001). The expression of E-cadherin mRNA was significantly higher in the shRNA-Sp3 group than in the other two groups (F = 66.983, P 〈 0.001). The expression levels of Sp3 (30 ± 5.69), β-catenin (28 ± 5.13) and MMP-9 proteins (97 ± 10.41) were significantly lower than those in the non-relevant group and control group (P = 0.000 for all). The expression of E-cadherin pro- tein (132 ± 4.36) was significantly higher in the shRNA-Sp3 group than in the other two groups (P = 0.000). CONCLUSION: Sp3 may influence the inva- sion of HepG2 cells in vivo by up-regulating the expression of β-catenin and MMP-9 and down- regulating the expression of E-cadherin.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第6期813-818,共6页 World Chinese Journal of Digestology
基金 广西科学研究与技术开发计划基金资助项目 No.桂科攻1298003-2-5 广西新世纪十百千人才工程专项基金资助项目 No.2007214 广西壮族自治区卫生厅自筹经费科研课题基金资助项目 No.Z2012052~~
关键词 沉默特异性蛋白3 裸鼠 Β-连接素 E-钙 黏附蛋白 基质金属蛋白酶9 Specificity protein 3 Nude mice β-catenin E-cadherin Matrix metalloproteinase 9
  • 相关文献

参考文献20

  • 1ChintharIapalIi S, Papineni S, Ramaiah SK, Safe S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 2007; 67: 2816-2823 [PMID: 17363604 DOI: 10.1158/0008-5472.CAN-06-3735].
  • 2Jutooru 1, Chadalapaka G, Sreevalsan S, Lei P, Barhoumi R, Burghardt R, Safe S. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Exp Cell Res 2010; 316: 2174-2188 [PMID: 20435036 DOI: 10.1016/j.yexcr.2010.04.027].
  • 3Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 2011; 11: 371 [PMID: 21864401].
  • 4Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 2007; 67: 11001-11011 [PMID: 18006846 DOI: 10.1158/0008-5472.CAN-07-2416].
  • 5Papineni S, Chintharlapalli S, Abdelrahim M, Lee SO, Burghardt R, Abudayyeh A, Baker C, Herrera L, Safe S. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. Carcinogenesis 2009; 30: 1193-1201 [pMID: 19406933 DOI: 10.1093/carcin/bgp092].
  • 6Gao Y, Jia Z, Kong X, Li Q, Chang DZ, Wei D, Le X, Suyun H, Huang S, Wang L, Xie K. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. Cancer Res 2011; 71: 5182-5193 [PMID: 21673052 DOI: 10.1158/0008-5472.CAN-10-2016].
  • 7Colon J, Basha MR, Madero-Visbal R, Konduri S, Baker CH, Herrera LJ, Safe S, Sheikh-Hamad D, Abudayyeh A, Alvarado B, Abdelrahim M. Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice. Invest New Drugs 2011; 29: 41-51 [PMID: 19851711 DOI: 10.1007/ s10637-009-9331-8].
  • 8陆会平,李佳,莫伟嘉,冯振博.RNAi沉默Sp3基因对肝癌HepG2细胞增殖的影响[J].世界华人消化杂志,2012,20(27):2595-2600. 被引量:4
  • 9梁治坤,黄志勇,陈孝平,刘聪,吴在德.5-杂氮-2'-脱氧胞苷诱导裸鼠HepG2种植瘤细胞T-cadherin的表达及其对种植瘤的抑制作用[J].世界华人消化杂志,2008,16(16):1741-1745. 被引量:4
  • 10Scohy S, Gabant P, Van Reeth T, Hertveldt V, Dreze PL, Van Vooren P, Riviere M, Szpirer J, Szpirer e. Identification of KLF13 and KLF14 (SP6), novel members of the SP /XKLF transcription factor family. Cenomics 2000; 70: 93-101 [PMID: 11087666 DOI: 10.1006/ geno.2000.6362].

二级参考文献67

  • 1张志发,严群,黄志勇.黏附分子cadherin与肝癌生物学特性的关系[J].世界华人消化杂志,2006,14(7):697-701. 被引量:5
  • 2Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH, Goggins M. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 2002; 160:1573-1581.
  • 3Santini V, Kantarjian HM, Issa JP. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 2001; 134: 573-586.
  • 4Wijermans PW, Krulder JW, Huijgens PC, Neve P. Continuous infusion of low-dose 5-Aza-2'- deoxycytidine in elderly patients with high-risk mvelodvsvlastic svndrome. Leukemia 1997; 11:1-5.
  • 5Kantarjian H, Oki Y, Garcia-Manero G, Huang X, O'Brien S, Cortes J, Faderl S, Bueso-Ramos C, Ravandi F, Estrov Z, Ferrajoli A, Wierda W, Shan J, Davis J, Giles F, Saba HI, Issa JP. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 2007; 109:52-57.
  • 6Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M, Hirohashi S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997; 71: 355-359.
  • 7Lee YY, Kang SH, Seo JY, Jung CW, Lee KU, Choe KJ, Kim BK, Kim NK, Koeffier HP, Bang YJ. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Cancer 1997; 80:1889-1896.
  • 8Vogt M, Haggblom C, Yeargin J, Christiansen-Weber T, Haas M. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ 1998; 9:139-146.
  • 9Sato N, Fukushima N, Maitra A, MatsubayashiH, Yeo CJ, Cameron JL, Hruban RH, Goggins M. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 2003; 63:3735-3742.
  • 10Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 2001; 61:4556-4560.

共引文献6

同被引文献35

  • 1吴军峰,童坦君,张宗玉.人成纤维细胞转录因子Sp1Sp3对p16^(INK4a)基因的调控[J].中国生物化学与分子生物学报,2005,21(1):88-93. 被引量:4
  • 2Pathi S,Jutooru I,Chadalapaka G,et al.Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors[J].PLoS One,2012,7(10):e48208.
  • 3Black AR,Black JD,Azizkhan-Clifford J.Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer[J].J Cell Physiol,2001,188(2):143-160.
  • 4Safe S,Kim K.Nuclear receptor-mediated transactivation through interaction with Sp proteins[J].Prog Nucleic Acid Res Mol Biol,2004,77:1-36.
  • 5Li L,He S,Sun JM,et al.Gene regulation by Sp1 and Sp3[J].Biochem Cell Biol,2004,82(4):460-471.
  • 6Davie JR,He S,Li L,et al.Nuclear organization and chromatin dynamics:Sp1,Sp3 and histone deacetylases[J].Adv Enzyme Regul,2008,48 (1):189-208.
  • 7Wong WK,Chen K,Shih JC.Decreased methylation and transcription repress or Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation[J].J Biol Chem,2003,278 (38):36227-36235.
  • 8Schwarzmayr L,Andorfer P,Novy M,et al.Regulation of the E2F-associated phosphoprotein promoter by GC-box binding proteins[J].Int J Biochem Cell Biol,2008,40(12):2845-2853.
  • 9Kennett SB,Udvadia A J,Horowitz JM.Sp3 encodes mul tiple proteins that differ in their capacity to stimulate or repress transcription[J].Nucleic Acids Res,1997,25(15):3110-3117.
  • 10Dennig J,Hagen G,Beato M,et al.Members of the Sp transcription factor family control transcription from the uteroglobin promoter[J].J Biol Chem,1995,270(21):12737-12744.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部